Background Nausea and vomiting is a common complication in parturients with cesarean delivery under spinal anesthesia it may causes significant distress to the patient and increases the chance of aspiration pneumonitis, it also affects the surgical procedure. Many drugs have been used to prevent this complication but none proved to be effective to abolish it completely. Objectives Subhypnotic dose of Midazolam or Propofol were evaluated to prevent intraoperative nausea and vomiting during elective cesarean section under spinal anesthesia. Methods This study is a randomized control clinical trial, after local ethical committee approval A 93 consenting (ASAII ) parturients, who underwent spinal anesthesia for caesarean section were divided randomly into three groups received Propofol (20 milligram bolus and 0.1 milligram /kilogram/hour by infusion immediately after the bolus dose, 30 parturients ), Midazolam (1 milligram bolus and 1 milligram/hour by infusion after bolus dose, 31 parturients ), and placebo (saline, 32 parturients ) intravenously after umbilical cord clamping. Bupivacaine 0.5% (12.5-15 milligram) used for spinal anesthesia. Intraoperative and post delivery emetic episodes were recorded. Results The incidence of nausea and vomiting was significantly less in the propofol and Midazolam groups in compared to placebo group. There was insignificant difference between Propofol and Midazolam group in postoperative nausea and vomiting (P = 0.616) and there were no significant hemodynamic changes in all the groups. Conclusion The use of Propofol is as effective as Midazolam in decreasing nausea and vomiting during Caesarean section under spinal anesthesia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.